Invest in Pharmaceuticals Industry in Ivory Coast ZIC

INVEST IN AFRICA NOW

Set-up your Business in Africa's Key Industrial Zones

Name *

Email *

Phone No. *

Investment Sector

Investment Opportunity

Investment Budget (USD)

How may we assist you?

*Note: Name, Email and Phone Number are mandatory.

I agree to the AFI privacy policy.*

I agree to receive e-communications from AFI.

THANK YOU

Our team will get back to you shortly.

In Cote d’Ivoire, 6% of pharmaceutical products are domestically produced, while 94% is imported, signifying a huge area for improvement.

$1.8 Bn by 2025

Forecast

he Ivorian pharmaceutical market is projected to reach USD 1.8 billion by 2025 (Statista), fueled by factors like a growing population, rising disposable incomes, and an increasing focus on healthcare access. This significant market expansion creates a lucrative space for ZIC-based manufacturers to cater to domestic needs and contribute to import substitution. Prioritizing the production of essential medicines can ensure a steady demand and contribute to improved healthcare access within Côte d'Ivoire and neighboring countries. Meeting international quality standards like WHO Good Manufacturing Practices (GMP) is crucial for gaining market trust and potentially exporting pharmaceuticals.

ZIC's proximity to Abidjan's port facilitates easy import of raw materials and export of finished pharmaceutical products. This strategic positioning allows companies to tap into regional markets within the Economic Community of West African States (ECOWAS), with a combined population exceeding 200 million (World Bank), offering significant export potential. Additionally, potential trade agreements within ECOWAS can further streamline regional pharmaceutical trade.

FACILITIES IN ZIC Pharmaceuticals